Measuring Patient Engagement

Patient engagement is becoming increasingly embedded in the drug development process, driven by both internal and external stakeholders. Externally, progressively aware and proactive patients are demanding more involvement in decisions involving their treatment, and regulatory pressures from global regulatory agencies are mounting. Internally, drug developers themselves are not only recognising that patient engagement is 'the right thing to do', but that it also drives success throughout the drug development process. While transformative progress has been made in engaging patients throughout the pharma value chain, there is work to be done when it comes to measuring, assessing and systematically reporting these efforts to internal and external stakeholders.

Dedicated to measuring the success of patient engagement throughout the drug development lifecycle, the inaugural Measuring Patient Engagement Summit serves as a pivotal platform to collectively build a standardized framework to measure the value of patient engagement and ensure that patient engagement remains a key driver for success in drug development.

Join 70+ Chief Patient Officers, Patient Engagement leaders and Patient Advocacy experts, from esteemed pharmaceutical and biotech companies, such as Novartis, Otsuka, Boehringer Ingelheim, AstraZeneca and many more, to establish a roadmap to quantify the success of your patient engagement work.

URLs:
Website: https://go.evvnt.com/2094576-0?pid=10018
Tickets: https://go.evvnt.com/2094576-2?pid=10018
Brochure: https://go.evvnt.com/2094576-3?pid=10018

Prices:
Drug Developer Pricing - Conference Only : USD 2999.00,
Drug Developer Pricing - Conference + Pre-Conference Workshop Day: USD 4197.00,
Solution Provider Pricing - Conference Only: USD 3699.00,
Solution Provider Pricing - Conference + Pre-Conference Workshop Day: USD 5197.00,
Non-For-Profit Pricing - Conference Only : USD 2599.00,
Non-For-Profit Pricing - Conference + Pre-Conference Workshop Day: USD 3597.00

Speakers: Anthony Pisa, Patient Advocate, Independant, Beyza Klein, Global Patient Engagement Director, Patient Insights and Measurements, Novartis AG, Dorothee Oberdhan, Director, Patient-Centric Outcomes, Otsuka, Emma Sutcliffe, Vice President and Head of Patient Affairs Global Officer, Ipsen Pharma, Eric Zhao, Executive Director, Head of Field and Patient Engagement, Black Diamond Therapeutics Inc., Eve Dryer, Vice President - Patient Advocacy Travere Therapeutics, Inc., Hannah Glenny Senior Manager Patient Engagement Strategies Otsuka, Marie Eckerd, Director - Patient Engagement Radiology and Imaging AstraZeneca, Mary Pomerantz, Senior Director - Patient Advocacy and Engagement Cytokinetics Inc, Michelle Barber, Associate Director, Patient Engagement Mural Oncology, Monique Milkern, Head Global Patient Insights and Solutions (GPIS), Patient Experience Team, Global Medical Affairs Alexion Pharmaceuticals, Nicole Nunez, Manager, Regulatory Affairs and Patient Engagement Eureka Therapeutics, Philip Green, Patient Advocate, I AM ALS, Ramona Burress, Head Of Patient Engagement, Insights, Center for Health Equity and Patient Affairs, Takeda Pharmaceutical Co. Ltd, Tiara Hayes, Senior Manager - Site and Patient Engagement, Otsuka, Vanessa Boulanger, Director of Patient Engagement, National Organization for Rare Disorders (NORD), Yiyi Xia, Director of Patient Value and Strategy, Alexion Pharmaceuticals